- Home
- ASND vs RGA Comparison
ASND vs RGA Comparison
Compare ASND & RGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASND | RGA |
|---|---|---|
| Founded | 2006 | 1973 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1B | 16.3B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ASND | RGA |
|---|---|---|
| Price | $275.95 | $274.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 10 |
| Target Price | ★ $307.57 | $285.11 |
| AVG Volume (30 Days) | ★ 613.7K | 400.1K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 18.91 |
| Revenue | N/A | ★ $23,698,000,000.00 |
| Revenue This Year | $91.76 | $16.70 |
| Revenue Next Year | $46.32 | $2.23 |
| P/E Ratio | ★ N/A | $14.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $188.08 | $182.73 |
| 52 Week High | $282.15 | $277.15 |
Technical Indicators
Market Signals| Indicator | ASND | RGA |
|---|---|---|
| Relative Strength Index (RSI) | 75.38 | 65.05 |
| Support Level | $216.52 | $242.32 |
| Resistance Level | $282.15 | N/A |
| Average True Range (ATR) | 6.95 | 5.79 |
| MACD | 2.38 | 0.52 |
| Stochastic Oscillator | 95.37 | 84.87 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
About RGA Reinsurance Group of America Incorporated
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.